Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastases

MLA

G Allevi, et al. “Changes of Bone Turnover Markers and Serum PTH after Night or Morning Administration of Zoledronic Acid in Breast Cancer Patients with Bone Metastases.” British Journal of Cancer, vol. 98, May 2008, pp. 1753–58. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....caacc2ee5791a73c77b075bb3c501f68&authtype=sso&custid=ns315887.

APA

G Allevi, Marcello Tucci, Mirella Torta, Sergio Aguggini, Manuela Milani, S Bonardi, Marco Tampellini, A Dovio, Daniele Generali, Alberto Angeli, Alberto Bottini, S Tedoldi, Alfredo Berruti, Adrian L. Harris, & Luigi Dogliotti. (2008). Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastases. British Journal of Cancer, 98, 1753–1758.

Chicago

G Allevi, Marcello Tucci, Mirella Torta, Sergio Aguggini, Manuela Milani, S Bonardi, Marco Tampellini, et al. 2008. “Changes of Bone Turnover Markers and Serum PTH after Night or Morning Administration of Zoledronic Acid in Breast Cancer Patients with Bone Metastases.” British Journal of Cancer 98 (May): 1753–58. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....caacc2ee5791a73c77b075bb3c501f68&authtype=sso&custid=ns315887.